AN2 Therapeutics GAAP EPS of -$0.21 beats by $0.13

* AN2 Therapeutics press release [https://seekingalpha.com/pr/20198548-an2-therapeutics-reports-second-quarter-2025-financial-results-and-recent-business-and] (NASDAQ:ANTX [https://seekingalpha.com/symbol/ANTX]): Q2 GAAP EPS of -$0.21 beats by $0.13.
* Cash, cash equivalents, and investments of $71.2 million at June 30,2025 and cash runway anticipated to fund operations into 2028.

MORE ON AN2 THERAPEUTICS

* Seeking Alpha’s Quant Rating on AN2 Therapeutics [https://seekingalpha.com/symbol/ANTX/ratings/quant-ratings]
* Historical earnings data for AN2 Therapeutics [https://seekingalpha.com/symbol/ANTX/earnings]
* Financial information for AN2 Therapeutics [https://seekingalpha.com/symbol/ANTX/income-statement]